Bladder cancer screening in a high risk asymptomatic population using the NMP22 BladderChek test

被引：0
|
作者：
Lotan, Yair [1 ]
Svatek, Robert [1 ]
Elias, Keren [1 ]
Moran, Brett [1 ]
Sagalowsky, Arthur [1 ]
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1606
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Usefulness of the NMP22BladderChek Test for Screening and Follow-up of Bladder Cancer
    Choi, Hwa Sub
    Lee, Sang Ik
    Kim, Dong Jun
    Jeong, Tae Yoong
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (02) : 88 - 93
  • [12] The nuclear matrix protein 22 (NMP 22) BladderChek™ test for the detection of bladder cancer
    不详
    JOURNAL OF ENDOUROLOGY, 2005, 19 : A176 - A176
  • [13] USING NMP22 BLADDER CHECK TEST IN DIAGNOSIS AND FOLLOW UP OF THE BLADDER CANCER
    Stevan J, Jordanoski
    Jakim R, Jakimoska Jordanoska
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 576 - 577
  • [14] Screening and monitoring for bladder cancer: Refining the use of NMP22
    Ponsky, LE
    Sharma, S
    Pandrangi, L
    Kedia, S
    Nelson, D
    Agarwal, A
    Zippe, CD
    JOURNAL OF UROLOGY, 2001, 166 (01): : 75 - 78
  • [15] Evaluation of urine NMP22 point-of-care test for the screening of bladder cancer
    Ihm, Chun Hwa
    Kim, Ji Myung
    Sohn, Yong-Hak
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (02): : 106 - 110
  • [16] NMP22 IS PREDICTIVE OF RECURRENCE IN HIGH RISK SUPERFICIAL BLADDER CANCER PATIENTS
    Yau, Paul
    Chin, Joseph L.
    Pautler, Stephen
    Razvi, Hassan
    Izawa, Jonathan I.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 641 - 641
  • [17] NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer
    Casella, R
    Lehmann, K
    Gasser, TC
    JOURNAL OF UROLOGY, 1999, 162 (02): : 500 - 501
  • [18] NMP22: A sensitive, cost-effective test in patients at risk for bladder cancer
    Zippe, C
    Pandrangi, L
    Potts, JM
    Kursh, E
    Novick, A
    Agarwal, A
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2621 - 2623
  • [19] NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer
    Zippe, C
    Pandrangi, L
    Agarwal, A
    JOURNAL OF UROLOGY, 1999, 161 (01): : 62 - 65
  • [20] NMP22® Bladder-Chek® test in the diagnosis of superficial bladder cancer
    Zaak, D
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (06) : 354 - 355
12345